Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154


Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits.

Chang L, Jiang C, Cunningham E, Buchthal S, Douet V, Andres M, Ernst T.

Neurology. 2014 Jun 17;82(24):2213-22. doi: 10.1212/WNL.0000000000000526. Epub 2014 May 21.


Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging.

Chang L, Andres M, Sadino J, Jiang CS, Nakama H, Miller E, Ernst T.

Neuroimage. 2011 Oct 15;58(4):1017-27. doi: 10.1016/j.neuroimage.2011.07.010. Epub 2011 Jul 21.


APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.

Gomar JJ, Gordon ML, Dickinson D, Kingsley PB, Uluğ AM, Keehlisen L, Huet S, Buthorn JJ, Koppel J, Christen E, Conejero-Goldberg C, Davies P, Goldberg TE.

Biol Psychiatry. 2014 May 1;75(9):686-92. doi: 10.1016/j.biopsych.2013.05.022. Epub 2013 Jul 5.


Increased glial metabolites predict increased working memory network activation in HIV brain injury.

Ernst T, Chang L, Arnold S.

Neuroimage. 2003 Aug;19(4):1686-93.


Decreases in Short Term Memory, IQ, and Altered Brain Metabolic Ratios in Urban Apolipoprotein ε4 Children Exposed to Air Pollution.

Calderón-Garcidueñas L, Mora-Tiscareño A, Franco-Lira M, Zhu H, Lu Z, Solorio E, Torres-Jardón R, D'Angiulli A.

J Alzheimers Dis. 2015;45(3):757-70. doi: 10.3233/JAD-142685.


A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.

Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA; HIV MRS Consortium.

Neuroimage. 2004 Dec;23(4):1336-47.


Age-related differences in white matter integrity and cognitive function are related to APOE status.

Ryan L, Walther K, Bendlin BB, Lue LF, Walker DG, Glisky EL.

Neuroimage. 2011 Jan 15;54(2):1565-77. doi: 10.1016/j.neuroimage.2010.08.052. Epub 2010 Sep 6.


Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.

Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JA, Letendre S, Ellis R, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Ances BM; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2016 Oct;22(5):607-614. Epub 2016 Mar 28.


Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.

Chang L, Ernst T, Speck O, Grob CS.

Am J Psychiatry. 2005 Feb;162(2):361-9.


Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.


Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.

Voevodskaya O, Sundgren PC, Strandberg O, Zetterberg H, Minthon L, Blennow K, Wahlund LO, Westman E, Hansson O; Swedish BioFINDER study group.

Neurology. 2016 May 10;86(19):1754-61. doi: 10.1212/WNL.0000000000002672. Epub 2016 Apr 15.


Effect of aging on brain metabolism in antiretroviral-naive HIV patients.

Ernst T, Chang L.

AIDS. 2004 Jan 1;18 Suppl 1:S61-7.


Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.

Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.

J Alzheimers Dis. 2015;45(3):781-95. doi: 10.3233/JAD-142556.


APOE polymorphisms and cognitive functions in patients with brain tumors.

Correa DD, Satagopan J, Baser RE, Cheung K, Richards E, Lin M, Karimi S, Lyo J, DeAngelis LM, Orlow I.

Neurology. 2014 Jul 22;83(4):320-7. doi: 10.1212/WNL.0000000000000617. Epub 2014 Jun 18.


Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.

Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E.

Neuroimage. 2002 Nov;17(3):1638-48.


Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers.

Caselli RJ, Dueck AC, Locke DE, Hoffman-Snyder CR, Woodruff BK, Rapcsak SZ, Reiman EM.

Neurology. 2011 Apr 19;76(16):1383-8. doi: 10.1212/WNL.0b013e3182167147.


Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.

Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, Lowe V, Senjem ML, Gunter JL, Machulda MM, Gregg BE, Pankratz VS, Rocca WA, Petersen RC.

JAMA Neurol. 2015 May;72(5):511-9. doi: 10.1001/jamaneurol.2014.4821.


Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.

Fennema-Notestine C, Panizzon MS, Thompson WR, Chen CH, Eyler LT, Fischl B, Franz CE, Grant MD, Jak AJ, Jernigan TL, Lyons MJ, Neale MC, Seidman LJ, Tsuang MT, Xian H, Dale AM, Kremen WS.

J Alzheimers Dis. 2011;26 Suppl 3:49-60. doi: 10.3233/JAD-2011-0002.


Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.


Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.


Supplemental Content

Support Center